More specifically, the second stage of the multi-purpose allele after recombinase conversion could be used for the conditional knockout of PTBP1 in pancreatic β-cells only [45] in order to test the role of this gene in insulin granule biogenesis and diabetes [18], [19], [46]. This evidence concerns the gene INS and diabetes mellitus.